220260.Kq

The company's capital structure shows a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position. However, the company has a negative net income of -11,841,396,870 KRW and a free cash flow of -23,228,829,560 KRW, which suggests significant financial strain. The liquidity position is further complicated by a current ratio of 0.67, indicating that the company's current liabilities exceed its current assets.

Profitability metrics are notably weak, with a return on equity of -21.64% and a return on assets of -9.53%. These figures are far below the typical performance of companies in the specialty chemicals industry, which usually exhibit positive returns. The company's operating income of 1,048,331,370 KRW is also significantly lower than the industry median, highlighting a substantial underperformance in operational efficiency.

The company's revenue is primarily concentrated in a single geographic region, with no disclosed segment breakdown. This lack of diversification increases the risk associated with the company's revenue streams, as it is highly dependent on the performance of one market. The absence of detailed segment data makes it difficult to assess the company's exposure to different markets and product lines.

The company's growth trajectory is concerning, with a negative net income and declining free cash flow. The capital expenditure of -15,257,228,690 KRW indicates a reduction in investment, which could hinder future growth. The company's operating cash flow of 585,175,580 KRW is insufficient to cover its capital expenditures, suggesting a potential need for external financing.

The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential difficulties in meeting short-term obligations. The dilution risk is low, but the company's financial strain may necessitate future equity issuances, which could dilute existing shareholders.

Recent events and filings do not provide specific details on the company's strategic initiatives or financial adjustments. The lack of recent disclosures makes it challenging to assess the company's response to market conditions and its plans for addressing its financial challenges.